Today's OTCBB Breakouts - COYN, PWEB, NWCI

COPsync, Inc. (COYN.OB 0.37 +12.12%), a law enforcement and emergency service software developer, is watching its stock rally sharply following the announcement that the company is exhibiting at the Sheriffs' Association of Texas 131st Annual Training Conference in Corpus Christi, Texas. The conference is being held from July 19th to the 22nd.

While COPsync's presence at the conference will certainly give the software company positive exposure, it's not likely the sole reason for today's move. The interest in these shares has been slowly building since late June. However, today's trading is still on pace to be the highest-volume day ever for this penny stock. If shares remain at the current price of 37 cents, COYN will close above its 20 day average for the first time since early June.

Pacific WebWorks, Inc. (PWEB.OB 0.29 +20.8%) shares are up more than 20% this morning on very strong volume. That, however, is nothing new for this penny stock - it's been up nearly every day since early May, and has gained nearly 1000% during that time. The July 14th mention of the company as a "Top 40 Public Company" in Utah Business Magazine is hardly attributable as the reason for the gains today.

Despite the apparent momentum, a lack of substantive news in the shadow of such a quick runup suggests this penny stock is technically overbought. Investors should be leery of these prices.

Pacific WebWorks provides a comprehensive suite of affordable software programs to small businesses needing interactive web sites including full e-commerce capabilities.

NewCardio, Inc. (NWCI.OB 1.00 +17.65%) shares are higher by 17.6% today in a high-volume session. Though the penny stock's trade volume is not yet at multi-week highs, it's on pace to reach that mark later today. Yet, there's no news to prompt the big gain.

The surge to $1.00 carried NWCI past July's resistance level of 90 cents. However, an even-stronger ceiling at $1.00 dates back to April, which is where today's rally has been halted so far. A break above the $1.00 mark should jump-start another wave of buying interest.

NewCardio is a cardiac diagnostic and services company focused on the development of a proprietary platform technology. The company's development-stage software and hardware products and services are intended to improve the diagnosis and monitoring of cardiovascular disease (CVD), as well as cardiac safety assessment of drugs under development. NewCardio's three-dimensional ECG platform is designed to reduce the time and expense involved in assessing cardiac status while increasing the ability to diagnose difficult-to-detect patient conditions.